Frequently Asked Questions What is GHK-Cu peptide therapy
41% of mAb products approved between 2015 and 2023 are administered by SC injection, whereas it was 24% between 1994 and 2014. About 79 mAb products, excluding antibody-drug conjugates (ADCs), were approved between 2015 and 2023, which is twice the number of products approved between 1994 and 2014 (31 products)
5-amino-1mq has not undergone human clinical trials and is not FDA approved for any medical use
While NAC was found to have no impact on force production during sustained maximal contractions, it was found to help reduce and inhibit glutathione oxidation during repetitive submaximal contractions
Selenium protects normal cell function by scavenging harmful free radicals
Over multiple draws across days or weeks, unpreserved solution can become contaminated compromising both the research data and the compound itself